Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody / Benhealth Biopharma

BK2016.01, NCT03146637: Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Recruiting

RoW

Activated CIK, CIK

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd., Beijing 302 Hospital

Advanced Liver Cancer

01/21

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites